The "usefulness" product: concern for cupping, control, and compliance.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D009883:Ophthalmic Solutions / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010349:Patient Compliance; D010862:Pilocarpine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D010862:Pilocarpine; D004837:Epinephrine